Healthy
Conditions
Keywords
single dose, pharmacokinetics, safety, healthy volunteers, food interaction, AZD1446
Brief summary
The primary purpose of this study is to assess the safety and tolerability of AZD1446 following single dose administration.
Interventions
oral, single dose
Sponsors
Study design
Eligibility
Inclusion criteria
* physical healthy volunteers * weight between 50 to 100 kg and a body mass index (BMI) between 19 and 30 kg/m2
Exclusion criteria
* History of any clinically significant disease or disorder. * History of severe allergy/hypersensitivity reactions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety and tolerability of AZD1446 by assessment of serious adverse events, ECGs, vital signs and laboratory variables | From first to last visit |
Secondary
| Measure | Time frame |
|---|---|
| Determine the single ascending dose pharmacokinetics of AZD1446 | PK sampling taken at defined timepoints during residential period |
| Determine the single dose of AZD1446 on food interaction | From first to last visit |
Countries
Sweden